Background
==========

Histopathologic examination is still the criterion standard for diagnosis of brain tumors. Surgical biopsies entail potential morbidity and mortality risks. The intraoperative microscopic diagnosis error rate is 3% to 8% \[[@b1-medscimonit-25-5886]\]. Accurate diagnosis in neuroimaging before treatment is usually necessary.

Ependymomas, choroid plexus papillomas (CPPs), and central neurocytomas (CNCs) are sometimes difficult to distinguish. Ependymomas and CPPs are usually seen in children and adults, while CNCs are more common in adults. They all can show as lobulated masses. Typical CPPs show homogeneous signal intensity, while CNCs have heterogeneity in T1WI and T2WI, and on DWI the solitary tissues of the tumors usually display reduced diffusion because of high tumor cellularity. Susceptibility artifacts can be seen in ependymomas because of internal calcifications or hemorrhage (calcifications in 50% of lesions, hemorrhage in approximately 10%) \[[@b2-medscimonit-25-5886]\]. CPPs can show flow voids. CNCs usually contain cystic regions, calcifications, and tumor vessels, which appear as signal voids on MRI \[[@b3-medscimonit-25-5886]\]. CNCs had a "bubbly" appearance on T2WI due to clusters of cysts of varying sizes \[[@b4-medscimonit-25-5886]\]. Due to the plasticity of ependymomas, they can grow through the foramina of Luschka, Magendie, and magnum \[[@b5-medscimonit-25-5886]\]. CPPs in the lateral ventricles may enter into the foramina of Monro, and the tumors in the fourth ventricle can go through the foramina of Luschka \[[@b6-medscimonit-25-5886]\]. CPPs exhibit elevated choline peak and depressed NAA. Elevated myoinositol levels on MRS suggest the presence of CPPs \[[@b7-medscimonit-25-5886]\]. CNCs show increased choline: creatine ratio, and glycine (3.55 ppm) on MRS is a rather specific marker \[[@b8-medscimonit-25-5886]\]. CPPs and CNCs can result in dilation of ventricles to varying degrees.

The aim of this study was to use ADC histograms of solid components to discriminate among ependymomas, CPPs, and CNCs.

Material and Methods
====================

Patients
--------

We used the surgical pathology database for the period of January 1, 2014 to November 1, 2018 in our hospital. Exclusion criteria were: (1) patients who received treatment before surgery; (2) not confirmed histologically by biopsy; (3) inadequate image quality; and (4) without enhanced-T1WI. A total of 60 patients (36 ependymomas, 10 CPPs, and 14 CNCs) met the inclusion criteria for our study. All methods were performed in accordance with the relevant guidelines and regulations, and all informed consent requirements were met. This retrospective study was approved by the Institutional Ethics Review Committee of our hospital.

Image analysis
--------------

Patients were examined with a 3T MR scanner (Siemens Skyra) with standard head coil. The MRI scan protocols included: axial T1WI (TR/TE=260.0/2.46 ms), axial T2WI (TR/TE=3800/93.0 ms), axial FLAIR (TR/TE=4500/93.0 ms), sagittal T2WI (TR/TE=4200/79 ms), axial DWI (b=0 and 1000 s/mm^2^, TR/TE=3500/119 ms, field of view=230 mm, thickness=5 mm, intersection gap =0.3mm, and layers=20), and contrast-enhanced T1WI (flow rate=2.0 mL/s, dose=0.2 ml/kg).

The ROI on the ADC image of the largest lay was selected by reference to enhanced-T1WI, DWI, and T2WI. One physician delineated ROI manually along the edge of the lesion and filled it in with red, excluding the various necrotic and cystic regions. MaZda software (version 4.7, the Technical University of Lodz, Institute of Electronics, *<http://www.eletel.p.lodz.pl/mazda/>*) was used to calculate ROI and get histogram parameters, including mean value, variance, skewness, kurtosis, and percentile values.

Statistical analysis
--------------------

Non-normally distributed data were assessed using the Kruskal-Wallis test. Multiple testing used Bonferroni correction. Non-normally distributed are shown as medians. Sensitivity, specificity, and area under the curve were calculated for the diagnostic procedures. Thresholds were chosen to maximize the Youden index. All statistical analyses were performed using SPSS (SPSS 23.0). A P-value \<0.05 was considered to be statistically significant.

Results
=======

From January 2015 until November 2018, a total of 60 patients were finally selected for the study. There were 36 patients with ependymomas, 10 patients with CPPs, and 14 patients with CNCs ([Figure 1](#f1-medscimonit-25-5886){ref-type="fig"}). More details about tumor characteristics are provided in [Table 1](#t1-medscimonit-25-5886){ref-type="table"} and [Figure 2](#f2-medscimonit-25-5886){ref-type="fig"}. Because all measurements were non-normally distributed, data are presented as medians.

There was a significant difference in average age of patients among the different tumor types. There was a significant difference in ADC percentile values (p=0.000), mean (p=0.000), variance (p=0.008), and skewness (p=0.020) ([Table 2](#t2-medscimonit-25-5886){ref-type="table"}). We found no significant difference in kurtosis. The Bonferroni test was used to compare the 2 groups, and we found that mean, skewness, and ADC percentile values between ependymomas and CNCs were significantly different (p\<0.017). Mean, skewness, perc.01%, perc.10%, perc.50%, and perc.90% between CPPs and CNCs were significantly different (p\<0.017). Differences between ependymomas and CPPs were not statistically significant (p\>0.017). Ependymomas showed significantly higher mean, perc.01%, perc.10%, perc.50%, perc.90%, and perc.99% than CNCs. Ependymomas had significantly lower skewness than CNCs. Histogram metrics derived from mean, perc.01%, perc.10%, perc.50%, and perc.90% were significantly lower in CNCs than in CPPs. CPPs showed significantly lower skewness than CNCs.

AUCs for the most significant ADC histogram parameters are shown in [Table 3](#t3-medscimonit-25-5886){ref-type="table"} and [Figure 3](#f3-medscimonit-25-5886){ref-type="fig"}. The perc.50% had better discriminative powers to differentiate ependymomas and CNCs, with optimal cutoff values as 86.50, yielding a sensitivity of 97.20% and a specificity of 85.70% ([Table 3](#t3-medscimonit-25-5886){ref-type="table"}). Optimal diagnostic performance to predict CPPs from CNCs (AUC=0.96, sensitivity=100.00%, specificity=85.70%) was obtained when setting perc.50%= 84.00 as the threshold value ([Table 4](#t4-medscimonit-25-5886){ref-type="table"}).

Discussion
==========

The purpose of the study was to analyze the histograms of ADC maps for differentiating ependymomas, CPPs, and CNCs. Previous studies have used histograms of ADC in the differentiation of fourth ventricular tumors and posterior fossa tumors \[[@b9-medscimonit-25-5886]--[@b11-medscimonit-25-5886]\]. Histograms can show more descriptive information about ADC values than mean ADC. The results show that ADC histogram parameters, especially perc.50%, might help to differentiate them.

Skewness and kurtosis
---------------------

Skewness is a parameter that measures a histogram's asymmetry. In theory, positive skewness means that the main distribution of the mass is focused on the left-hand side of the graph, which indicates that there is high cellularity or possibility of malignancy. Negative skewness, where the main distribution of the mass is focused on the right-hand side of the graph, suggests a large amount of cystic or edematous tissue \[[@b12-medscimonit-25-5886]\]. When ROIs were placed, various necrotic and cystic areas were excluded. Therefore, skewness was mainly manifested as positive. CNCs showed the highest skewness, followed by ependymomas and CPPs. Although the sensitivities were not high, the results were consistent with the variation trend of skewness, suggesting that there was a potential difference in the density of the 3 types of tumor cells. The kurtosis of histograms was the statistic describing the distribution of degree of steepness of all values in the whole, which reflected the relative sharpness or flatness of a distribution compared with normal distribution. A positive peak indicated a sharper distribution than normal distribution and a negative peak indicated a flatter distribution than normal distribution. However, no significant difference was found, possibly due to the small sample size of the fact that there were 3 times as many ependymomas as CPPs.

Mean and ADC percentile values
------------------------------

The mean and ADC percentile values of CNCs were significantly lower than those of ependymomas, and the result was similar to those reported previously \[[@b13-medscimonit-25-5886]\]. Bull et al. found that the mean ADC and the max of ADC of CPPs were significantly higher than those of ependymomas, and the min of ADC of CPPs were slightly lower than those of ependymomas \[[@b11-medscimonit-25-5886]\]. However, ADC histograms of CPPs and ependymomas were not found to be significantly different in Bonferroni correction in our study. There have been previous studies on differential diagnosis of CPPs and CNCs in MRI \[[@b11-medscimonit-25-5886]\], but our study used a new method to analyze them. We found that mean, perc.01%, perc.10%, perc.50%, and perc.90% of CPPs were significantly higher than those of the CNCs. Correspondingly, those parameters had relatively good AUC values, with high sensitivity (100%). Kang et al. and Woo et al. reported that low ADC value reflected high cell compositions and high ADC value was correlated with mucoprotein \[[@b14-medscimonit-25-5886],[@b15-medscimonit-25-5886]\]. Therefore, we assumed that the tumor cellularity and mucoprotein component of CPPs were higher than those of CNCs. Further research with larger samples is needed.

Our study had some limitations. The size of the sample was small, the number of patients for each tumor was unbalanced, and further studies with larger sample sizes are needed. In addition, a manually traced boundary has unavoidable errors. Finally, conventional MRI features sometimes fail to differentiate among typical ependymomas, CPPs, and CNCs. Further studies using conventional MRI features, histograms of T2WI, and enhanced-T1WI are warranted.

Conclusions
===========

This study shows that histograms of ADC can improve the diagnostic performance to differentiate among ependymomas, CPPs, and CNCs.
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![Representative cases of ependymomas (**A--D**), CPPs (**E--H**), and CNCs (**I--L**). The left column showed axial ADC of a 3-year-old boy patient with ependymoma, that of a 29-year-old woman with CPP, and that of a 28-year-old woman with CNC (**A, E, I**). Enhanced-T1WI were conducted (**C, G, K**). Corresponding ROI and histogram maps are shown (**B, D, F, H, J, L**).](medscimonit-25-5886-g001){#f1-medscimonit-25-5886}

![The left picture shows mean, perc.01%, perc.10%, perc.50%, perc.90%, and perc.99% for the patient groups with ependymomas and CNCs. The right picture shows mean, perc.01%, perc.10%, perc.50%, and perc.90% for patient groups with CPPs and CNCs.](medscimonit-25-5886-g002){#f2-medscimonit-25-5886}

![ROC curves of significant ADC histogram features for differentiating among ependymomas, CPPs, and CNCs. The left picture shows ROC curves of mean, perc.01%, perc.10%, perc.50%, perc.90%, and perc.99% for differentiating ependymomas and CNCs. The right picture shows ROC curves of mean, perc.01%, perc.10%, perc.50%, and perc.90% for differentiating CPPs and CNCs.](medscimonit-25-5886-g003){#f3-medscimonit-25-5886}

###### 

Characteristics of patients with ependymomas, CPPs, and CNCs.

               Ependymomas   CPPs         CNCs
  ------------ ------------- ------------ ---------------
  Number       36            10           14
  Age, years   7 (1--66)     16 (1--51)   26.5 (18--38)
  Sex                                     
   Male        18            4            11
   Female      18            6            3

###### 

Parameters of patients with ependymomas, CPPs, and CNCs.

  Tumor         Skewness   Kurtosis   Mean     Variance   Perc.01%   Perc.10%   Perc.50%   Perc.90%   Perc.99%
  ------------- ---------- ---------- -------- ---------- ---------- ---------- ---------- ---------- ----------
  Ependymomas   0.22       −0.07      122.36   94.03      96.50      112.00     112.00     141.50     155.50
  CPPs          0.035      −0.15      106.89   66.93      89.00      93.00      108.00     125.00     133.00
  CNCs          0.58       0.80       62.35    42.77      51.00      55.00      61.50      69.00      78.50
  H             7.804      5.480      27.132   9.564      25.152     26.035     27.578     27.324     22.129
  p             0.020      0.065      0.000    0.008      0.000      0.000      0.000      0.000      0.000

###### 

ROC analysis of ADC histogram features for discriminating ependymomas from CNCs.

  Parameters   AUC     Cutoff value   Sensitivity   Specificity   p
  ------------ ------- -------------- ------------- ------------- -------
  Mean         0.966   70.07          100.00        78.60         0.000
  Skewness     0.710   0.53           57.10         77.80         0.002
  Perc.01%     0.948   69.50          97.20         85.70         0.000
  Perc.10%     0.956   76.00          97.20         85.70         0.000
  Perc.50%     0.968   86.50          97.20         85.70         0.000
  Perc.90%     0.968   95.50          94.40         85.70         0.000
  Perc.99%     0.921   101.00         94.40         78.60         0.000

###### 

ROC analysis of ADC histogram features for discriminating CPPs from CNCs.

  Parameters   AUC     Cutoff value   Sensitivity   Specificity   p
  ------------ ------- -------------- ------------- ------------- -------
  Mean         0.943   84.49          100.00        85.70         0.004
  Skewness     0.886   0.34           64.30         100.00        0.012
  Perc.01%     0.943   68.00          100.00        85.70         0.004
  Perc.10%     0.943   73.50          100.00        85.70         0.004
  Perc.50%     0.957   84.00          100.00        85.70         0.003
  Perc.90%     0.943   93.00          100.00        78.60         0.004
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